NewsRoom Articles - Page 36 of 251

FridayApr 22, 2022 9:00 am

Hero Technologies Inc. (HENC) Looks to Expand as States Report $3.7B in Cannabis Recreational Tax Revenue in 2021

MPP report notes that states with legalized marijuana for adult use generated $3.7 billion in tax revenue from recreational cannabis sales HENC is looking to leverage its cannabis expertise in more of these states Company is aggressively pursuing expansion into Colorado, Massachusetts A new report reveals that states with legalized recreational marijuana collected an estimated $3.7 billion in tax revenues last year (https://cnw.fm/xP9p5). That news bodes well for savvy players in the legal cannabis space, including Hero Technologies (OTC: HENC), as states are often eager to support revenue sources. “States that have legalized marijuana for adult use collectively generated more than…

WednesdayApr 20, 2022 9:30 am

Hero Technologies Inc. (HENC) Eyes Passage of Marijuana Act as Plans Include Expansion into Colorado, Massachusetts

U.S. House passes key cannabis bill to remove cannabis from federally banned substances A 2021 Pew Research Center poll indicates 91% of Americans agree that either medical or recreational cannabis use should be allowed HENC plans to expand into two states — Colorado and Massachusetts — that have legalized cannabis For the second time, the U.S. House of Representatives has passed a bill designed to end the federal ban on marijuana, which a Reuters article says has “created legal headaches for users and businesses in the states that have legalized” the substance (https://cnw.fm/guV9E). The bill now heads to the Senate,…

WednesdayApr 20, 2022 9:15 am

Flora Growth Corp. (NASDAQ: FLGC) Celebrates Finalization of Colombian Cannabis Export Protocols

Global cannabis brand Flora Growth Corp. is enjoying new opportunities for supplying its Colombian-grown high-THC and high-CBD flower to international markets, thanks to the finalization of regulatory framework allowing legal cannabis exports from the South American country Flora Growth is authorized to export non-psychoactive cannabidiol (“CBD”) products as well as up to 43,600 kg of products with high-tetrahydrocannabinol (“THC”) psychoactive cannabis content Flora Growth’s Cosechemos cultivation facility in central Colombia is currently capable of producing 600 kg of dried cannabis daily, as well as over 10,000 kg of cannabis derivatives annually under EU-GMP guidelines During the past 10 years, the…

MondayApr 18, 2022 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advances its Human Nicotine Study and Announces New Nicotine Formulation Creation and Evaluation Program with Altria

Lexaria’s patented DehydraTECH(TM) technology has proven, in the NIC-A21-1 animal study, to be 10-20 times faster in reaching peak delivery of nicotine to the bloodstream than controls The company hopes to affirm this in the NIC-H22-1 human nicotine study as their DehydraTECH-nicotine pouch performance will be compared to existing leading brands currently sold in the United States such as ON! and Zyn Lexaria has separately announced new agreements with Altria that will see the company receive a fee to provide certain DehydraTECH powder-based nicotine formulations that Altria will evaluate The company hopes that this, coupled with the human clinical study,…

ThursdayApr 14, 2022 9:30 am

The Southeastern Hemp & Medical Cannabis Convention by Organa Kannalytics LLC, Driving Forward The Medical Cannabis and Hemp Industry

The Southeastern Hemp & Medical Cannabis Convention (“SHMC”) is being held as a live event on May 12-14, 2022, at the Cobb Galleria Centre, Two Galleria Parkway, Atlanta, Georgia. Cannabis and hemp businesses, researchers, cultivators, medical practitioners, legislators, and enthusiasts are invited to attend the industry’s leading convention that explores all the aspects of the cannabis and hemp industry. Attendees can leverage the huge networking opportunities and connect with potential clients, experts, and investors at the SHMC event. The event will include industry leaders and enthusiasts who will impart their in-depth knowledge and expertise about cannabis trading, research, medicinal uses, and…

ThursdayApr 14, 2022 9:00 am

Advanced Container Technologies Inc.’s (ACTX) Grow Pods Offer Attractive Investment Option for Entry into Indoor Farming

Modular indoor farming is expected to grow to $9.7 billion worldwide by 2026 The “Times” reports that controlled-environment agriculture, including indoor farms, is attracting venture capitalists ACT’s Grow Pods are essentially micro-farms that can be placed anywhere and allow cultivation 365 days a year Modular indoor farms are expanding as the demand for year-round produce steadily increases, reports the “New York Times” last week (https://cnw.fm/0zpqd). That upward swing is not news to Advanced Container Technologies (OTC: ACTX), a savvy company that has been pioneering the idea through the distribution of self-contained, automated, indoor micro-farms called Grow Pods. “Vertical farming is expected…

TuesdayApr 12, 2022 9:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX): A Review of Its Research Developments

Lexaria Bioscience, the global innovator behind DehydraTECH drug delivery technology, has continuously focused on research into its patented technology The company has conducted both in vitro testing and in vivo animal and human testing to evaluate the ability of DehydraTECH to improve the delivery of various APIs (active pharmaceutical ingredients) Lexaria has multiple other studies lined up aimed at building sufficient data to effect meaningful industry and/or regulatory progress and sustainable increases in valuation As it moves toward national and international implementation and commercialization of its patented DehydraTECH(TM) drug delivery technology, Lexaria Bioscience (NASDAQ: LEXX) is aware of the need…

TuesdayApr 12, 2022 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Gaining Advantage on Processing Rare Cannabinoids with the Help of Subsidiary Bay Medica

There is an urgent need for large-scale biosynthetic processing that preserves the purity and consistency of cannabinoids Acquired by InMed in October 2021, Bay Medica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector InMed has two cannabinol formulations currently in development for ocular and dermatological diseases – INM-088 (ocular for glaucoma) and INM-755 (dermatological cream for epidermolysis bullosa) The global cannabis market increased exponentially after the pandemic hit, and is anticipated to continue its upward trend over the next few years. The market was valued at $20.47 billion…

TuesdayApr 12, 2022 9:00 am

Advanced Container Technologies Inc. (ACTX) Makes Mark at CannaCon Conference, Strengthens Foothold in Growing Market

The company exhibited at the premier event, held March 31–April 1, 2022 ACT has worked to strengthen its presence in the cannabis space This strategic positioning comes as the global cannabis packaging market is projected to reach $297.51 billion by 2026 Advanced Container Technologies (OTC: ACTX) recently wrapped up a successful appearance at the CannaCon Conference, showcasing its new product line and strengthening brand awareness. The company exhibited at the premier event, held March 31–April 1, 2022, alongside Grassfire Distro, ACT’s exclusive packaging reseller (https://cnw.fm/sLimf). Prior to the two-day event, Advanced Container Technologies CEO Doug Heldoorn noted that ACT had…

WednesdayApr 06, 2022 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT products The company recently reported its first revenues from CBC sales in the wake of its acquisition of rare cannabinoids manufacturer BayMedica late last year The company is also working to develop synthetic CBN cannabinoids as potential medical treatments for select conditions,…

News and publishing service for hemp related companies

Contact us: 512.354.7000